On July 30, 2026, Saudi Pharmaceutical Industries and Medical Appliances Corp. (SPIMACO) announced the signing of distribution agreements with Cigalah Medical Company's subsidiaries — Cigalah Drug Store in the UAE and Cigalah Gulf Medical in Qatar — effective July 29, 2026. Under the agreements, Cigalah Medical Company will serve as SPIMACO's second distributor in these markets, operating under mutually agreed terms and conditions. The contracts carry no fixed value, as the agreement's worth is tied to operational volumes in the targeted markets, and no immediate financial impact is expected. The agreements are valid for five years, renewable for an additional two years.

Original announcement:

Important Notice: The announcement information and market data in this report are sourced directly from the Saudi Exchange (Tadawul). This summary is generated by Sahm’s proprietary AI model for informational purposes only. While we strive for accuracy, it should not be construed as financial advice or an investment recommendation.